Page last updated: 2024-08-21

nandrolone and Heart Diseases

nandrolone has been researched along with Heart Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fineschi, V1
Germanakis, I; Kavvalakis, M; Kouretas, D; Ozcagli, E; Tsarouhas, K; Tsatsakis, AM; Tsitsimpikou, C; Tzardi, M; Vasilaki, F1
da H Silva, A; dos Santos, MC; Ferraz, EF; Marques Neto, SR; Nascimento, JH1
KALLIOMAEKI, JL; SEPPAELAE, P1
Bargheer, R; Fiegel, G; Kukwa, D1
Chekunova, MP; Minkina, NA; Suvorov, IM1
Bargheer, R; Fiegel, G1

Other Studies

7 other study(ies) available for nandrolone and Heart Diseases

ArticleYear
Chronic, supra-physiological doses of nandrolone decanoate and exercise induced cardio-toxicity in an animal-model study.
    Acta physiologica (Oxford, England), 2013, Volume: 208, Issue:2

    Topics: Anabolic Agents; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Diseases; Nandrolone; Nandrolone Decanoate; Physical Conditioning, Animal; Rats

2013
Cardiotoxicity in rabbits after long-term nandrolone decanoate administration.
    Toxicology letters, 2016, Jan-22, Volume: 241

    Topics: Anabolic Agents; Animals; Antioxidants; Biomarkers; Cardiotoxicity; Catalase; Endomyocardial Fibrosis; Heart Diseases; Injections, Intramuscular; Injections, Subcutaneous; Male; Myocardium; Nandrolone; Nandrolone Decanoate; Oxidative Stress; Rabbits; Telomerase; Thiobarbituric Acid Reactive Substances; Ultrasonography

2016
The blockade of angiotensin AT1 and aldosterone receptors protects rats from synthetic androgen-induced cardiac autonomic dysfunction.
    Acta physiologica (Oxford, England), 2013, Volume: 208, Issue:2

    Topics: Anabolic Agents; Angiotensin II Type 1 Receptor Blockers; Animals; Heart Diseases; Losartan; Male; Mineralocorticoid Receptor Antagonists; Nandrolone; Nandrolone Decanoate; Random Allocation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Spironolactone

2013
NORANDROSTENOLONE DECANOATE AS A CARDIAC ANABOLIZER STUDIED BY MEANS OF ELECTROCARDIOGRAPHIC CHANGES.
    Cardiologia, 1963, Volume: 43

    Topics: Arthritis; Arthritis, Rheumatoid; Cerebrovascular Disorders; Coronary Disease; Decanoates; Diabetes Mellitus; Electrocardiography; Heart Diseases; Hernia, Diaphragmatic; Humans; Hypertension; Leukemia; Nandrolone; Nandrolone Decanoate; Pulmonary Emphysema; Pyelonephritis; Subphrenic Abscess

1963
[Modification of lipid metabolism by anabolic agents].
    Arzneimittel-Forschung, 1966, Volume: 16, Issue:2

    Topics: Anabolic Agents; Cholesterol; Ethylestrenol; Female; Heart Diseases; Humans; Lipids; Male; Methandrostenolone; Methyltestosterone; Middle Aged; Nandrolone; Oxymetholone; Phospholipids; Testosterone

1966
[Pathogenetic therapy procedures in cobalt lesions of the myocardium].
    Gigiena truda i professional'nye zabolevaniia, 1978, Issue:12

    Topics: Acute Disease; Animals; Cobalt; Decanoates; Drug Evaluation, Preclinical; Heart Diseases; Male; Methionine; Nandrolone; Rats; Thioctic Acid; Unithiol

1978
[Catamnestic results following therapy of heart patients with anabolic steroids].
    Medizinische Klinik, 1966, Nov-25, Volume: 61, Issue:47

    Topics: Adult; Anabolic Agents; Androgens; Female; Heart Diseases; Humans; Male; Methandrostenolone; Methenolone; Methyltestosterone; Middle Aged; Nandrolone; Oxymetholone; Testosterone

1966